Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001828750-22-000002
Filing Date
2022-12-16
Accepted
2022-12-16 14:42:34
Documents
1
Effectiveness Date
2022-12-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12812
  Complete submission text file 0001828750-22-000002.txt   13850
Mailing Address 30301 AGOURA ROAD, #210 AGOURA HILLS CA 91301
Business Address 30301 AGOURA ROAD, #210 AGOURA HILLS CA 91301 805-491-1988
A2 Biotherapeutics, Inc. (Filer) CIK: 0001828750 (see all company filings)

EIN.: 822253911 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-465076 | Film No.: 221467645